LUMOS DIAGNOSTICS HOLDINGS LIMITED

Press Releases Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E. Other stock markets 01:59:20 2024-04-30 am EDT			5-day change	1st Jan Change
0.05 ^AUD	-5.66%		-10.71%	-31.51%

Apr. 09	Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	MT
Feb. 27	Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Diagnostics Appoints Doug Ward as CEO	22-06-21	GL
Lumos Diagnostics Appoints Doug Ward as CEO	22-06-21	AQ
Lumos Diagnostics : Letter to Eligible Shareholders	22-06-09	PU
Lumos Diagnostics : Operational Update and Accelerated Entitlement Offer	22-06-06	PU
Lumos Diagnostics : Notification regarding unquoted securities - LDX	22-03-31	PU
Lumos Diagnostics : FY2022 Half Year Update	22-02-27	PU
Lumos Diagnostics : Appendix 4D and Half Year Report	22-02-27	PU
Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies	22-01-12	BU
Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada	21-11-03	BU
Lumos Diagnostics : Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually	21-10-06	BU
Lumos Diagnostics : Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser	21-09-14	BU
Lumos Diagnostics : FY21 Full Year Results	21-08-30	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer